The neurotargeting research group has a broad range of expertise. Advances in molecular neurobiology now provide possibilities for the development of new therapies designed for treatment of neurological and psychiatric disorders. This type of translational research requires competency in both basic molecular research and experience in practical treatment.
The group involves three principal investigators. Please visit their lab pages to learn more about their research.
Recent news
Collaborators